however, a physician may determine that CINV symptoms are eligible for medical marijuana treatment when present with the qualifying condition of cancer.1

| 1. Discuss any prescription medications you are taking, including those for cancer, pain, depression, or autoimmune disorders. |
2. Report and discuss any concerning effects of medical marijuana with your physician. |
| Tell your provider about any other health problems you have. There are many possible interactions between medical marijuana and diseases, or other substances. Some medicines may need dose adjustments guided by a physician.4 | The use of medical marijuana can cause confusion, dizziness, dry mouth and worsen nausea and vomiting symptoms.4,6 Therefore, regular communication with your healthcare provider can assist in identifying risks and side effects. |
Please note: This document is for informational purposes only, but is not medical or legal advice and should not be used to make healthcare decisions. Please consult your healthcare provider to find out what treatment options are available for you.
1The 2020 Florida Statutes. Title XXIX, Chapter 381, section 381.986: Medical use of marijuana.
2American Cancer Society. Nausea and vomiting caused by cancer treatment. American Cancer Society. https://www.cancer.org/can- cer/managing-cancer/side-effects/eating-problems/nausea-and-vomiting/caused-by-treatment.html. Accessed March 9, 2026.
3Paul J. Hesketh et al. Antiemetics: ASCO Guideline Update. J Clin Oncol 38, 2782-2797(2020). DOI:10.1200/JCO.20.01296
4Ilana M. Braun et al. Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. J Clin Oncol 42, 1575-1593(2024).DOI:10.1200/JCO.23.02596. Accessed February 19, 2026.
5Chow R, Basu A, Kaur J, et al. Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis. Support Care Cancer. 2025;33(3):193. doi:10.1007/s00520-025-09251-w
6Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic Use of Cannabis and Cannabinoids: A Review. JAMA. 2026;335(4):345–359. doi:10.1001/ja- ma.2025.19433
Updated 2026